Media Summary: Every once in a while, interest in psychedelics as a way to treat mental health disorders is evoked. There's an extensive body of ... Biotech has been hit harder than any other industry over the last 18 months, but this could be the same industry that pulls North ... In the speculative world of 'psychedelic' biotech, companies that are under-capitalized or lacking pipeline diversity face an uphill ...
Inside Atai Life Sciences The - Detailed Analysis & Overview
Every once in a while, interest in psychedelics as a way to treat mental health disorders is evoked. There's an extensive body of ... Biotech has been hit harder than any other industry over the last 18 months, but this could be the same industry that pulls North ... In the speculative world of 'psychedelic' biotech, companies that are under-capitalized or lacking pipeline diversity face an uphill ... Presented as part of the CSE and CFN Media's exclusive video series on Investing in Psychedelics. This interview with Dr. Srinivas Rao, MD, Ph.D. is the Chief Scientific Officer at
